Acorda Therapeutics Company
Acorda Therapeutics, Inc. is an American biotechnology company based in Ardsley, New York. The company develops therapies that improve neurological function in people with Parkinson’s disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.
Investors
%20.jpg)
Headquarters:
United States
Number Of Exists:
N/A
Founded Date:
1995
Employee Number:
251-500
Investment Stage:
N/A
Investor Type:
Company
Technology:
Immunotherapy
Funding Status:
IPO
Estimated Revenue:
$50M to $100M
Industry:
Loss of Proteostasis